Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Debt / NOTE 4.000% 4/0
-
Number of holders
-
4
-
Total 13F principal, excl. options
-
92,440,000
-
Principal change
-
+4,972,900
-
Total reported value, excl. options
-
$73,128,000
-
Value change
-
+$2,461,396
-
Number of buys
-
3
-
Number of sells
-
2
-
Price
-
$0.7900
Institutional Holders of TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 as of Q3 2018
As of 30 Sep 2018 TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 had 6 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $92,440,000 principal (par value or face value) of the bond of the company.
Largest 6 bondholders included CITADEL ADVISORS LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, STONEHILL CAPITAL MANAGEMENT LLC, Linden Advisors LP, Wellesley Asset Management, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This table shows 6 bond principal holders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.